- Category
- Medium (2024-25)
- Udyam number
- UDYAM-MH-19-0004490

About Purple Microport Cardiovascular Private Limited
Data last updated:
Purple Microport Cardiovascular Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the medical and laboratory equipment segment of the healthcare sector. It was incorporated on 27 August 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U85100MH2007PTC173490. Its GSTIN is 27AAECP3664L1Z0 (Maharashtra). The company holds 6 GST registrations, of which 4 are active.
The company has an authorised share capital of ₹12.25 Cr and a paid-up capital of ₹1.85 Cr. It was formerly known as Purple Medical Solutions Private Limited. It is led by directors including Brian Savio Lancelot and Rajesh Hiralal Shrivas.
Its last annual general meeting (AGM) was held on 19 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 615/616 Avior Nirmal Galaxy L.B.S. Road Mulund West, Mumbai, Maharashtra, India – 400080.
As per the financials filed for FY 2025, the company reported a revenue of ₹100.49 Cr, a decline of 12% compared to the previous year. For the same year it recorded a net profit of ₹4.82 Cr (net margin 4.8%) and EBITDA of ₹11.43 Cr (EBITDA margin 11.4%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 22% over five years.
The company has about 143 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Purple MicroPort. As per MCA filings, the company has open charges of ₹64.52 Cr and satisfied charges of ₹13.2 Cr on record. Court records list 2 cases involving the company, including 2 filed by the company. The company has 9 deals on record (6 secondary share transfers, 3 funding rounds), with disclosed funding of ₹55.08 Cr; the latest was in December 2021.
Purple Microport Cardiovascular Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0004490). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website purplemicroport.com.
Company details
Recognitions & Rankings of Purple Microport Cardiovascular
Contact details
Purple Microport Cardiovascular Private Limited's registered office is in Mumbai, Maharashtra. Its website is purplemicroport.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address615/616 Avior Nirmal Galaxy L.B.S. Road Mulund West, Mumbai, Maharashtra, India – 400080
- IndustryHealthcare, Medical & Laboratory Equipment
To see the full contact details of Purple Microport Cardiovascular Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Purple Microport Cardiovascular operates one associated brand: Purple MicroPort. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Cardiovascular medical devices, including stents and pacemakers, are developed. | purplemicroport.com |
Business activity
The main business activity of Purple Microport Cardiovascular is manufacturing. In detail, this covers other manufacturing including jewellery, musical instruments, medical instruments, sports goods, etc. activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C13 | Other manufacturing including jewellery, musical instruments, medical instruments, sports goods, etc. activities |
To see the full business activity and turnover split of Purple Microport Cardiovascular Private Limited, buy the company report.
Financials of Purple Microport Cardiovascular Private Limited
FY 2025 filings availablePurple Microport Cardiovascular Private Limited reported revenue of ₹100.49 Cr (down 12% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 12% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 22%. EBITDA fell 6% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹11.43 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4.82 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 11.4% | ||||
| Net Profit Margin | 4.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Purple Microport Cardiovascular Private Limited, buy the company report.
Board of directors of Purple Microport Cardiovascular Private Limited
Purple Microport Cardiovascular has 3 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Brian Savio Lancelot | Director | 10 Jul 2010 | 16 Years 3 Months | Current |
| Rajesh Hiralal Shrivas | Director | 10 Jul 2010 | 16 Years 3 Months | Current |
| Jonathan W Chen | Director | 11 Nov 2021 | 4 Years 11 Months | Current |
Auditor
Purple Microport Cardiovascular Private Limited is audited by Jignesh Savla & Associates for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Jignesh Savla & Associates | FY 2024 | 127654W |
Shareholding
The shareholding of Purple Microport Cardiovascular Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Purple Microport Cardiovascular Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 09 May 2023 | 100751554 | Others | ₹30 Cr | Open | |
| 03 Feb 2023 | 100724695 | Axis Bank Limited | ₹1.1 Cr | Open | |
| 25 Nov 2020 | 100390727 | Axis Bank Limited | ₹2.19 Cr | Open | |
| 03 Apr 2018 | 100182432 | Axis Bank Limited | ₹4.88 Cr | Open | |
| 28 Aug 2013 | 10445624 | Axis Bank Limited | ₹21.38 Cr | Open |
To see the full charge records of Purple Microport Cardiovascular Private Limited, buy the company report.
Total charge records: 11 View all charges
Deals & funding
Purple Microport Cardiovascular Private Limited has 9 deals on record (6 secondary share transfers, 3 funding rounds), with disclosed funding of ₹55.08 Cr; the latest was in December 2021.
Deals on record (5 of 9)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Dec 2021 | Secondary share transfer | Undisclosed | Seller: 4 individuals |
| Mar 2020 | Secondary share transfer | Undisclosed | Buyer: Microport Scientific India Private Limited Seller: 4 individuals |
| Mar 2020 | Funding round | ₹50.84 Cr | Investors: Microport Scientific India Private Limited |
| Jul 2012 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: an individual |
| Mar 2012 | Secondary share transfer | Undisclosed | Buyer: Magan Mercantile Private Limited Seller: Ero Management Consulting Private Limited |
To see the full deal history of Purple Microport Cardiovascular Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Purple Microport Cardiovascular Private Limited has 2 court cases on record: 2 filed by Purple Microport Cardiovascular. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| Supreme Court | 2 | 0 | 0 |
Cases on record (1 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Supreme Court | Court case (1100-Arbitration Matters : SLPs challenging Arbitration Matters) | Filed by the company against Miv Therapeutics Inc | Disposed |
To see the full case history of Purple Microport Cardiovascular Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Purple Microport Cardiovascular Private Limited was last rated by Crisil on 21 Dec 2020.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 21 Dec 2020 |
To see the full credit ratings and regulatory alerts of Purple Microport Cardiovascular Private Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Purple Microport Cardiovascular Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Purple Microport Cardiovascular Private Limited has a workforce of 143 employees on its EPFO records as of Dec 26, 2024, across 2 active EPFO establishments.
GST
Purple Microport Cardiovascular has 6 GST registrations: 4 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAECP3664L1Z0 | Maharashtra | Active | 01 Jul 2017 |
| 32AAECP3664L1Z9 | Kerala | Active | 01 Jul 2017 |
| 07AAECP3664L2Z1 | Delhi | Active | 23 Jul 2017 |
| 24AAECP3664L2Z5 | Gujarat | Active | 26 Jun 2020 |
To see the full GST registrations and return filing status of Purple Microport Cardiovascular Private Limited, buy the company report.
Recent activity
Purple Microport Cardiovascular Private Limited has 9 board changes on record since 2010: 3 appointments and 6 cessations. The latest: Jonathan W Chen was appointed as Director on 11 Nov 2021.
23 earlier events are in the company report.
Frequently asked questions
Purple Microport Cardiovascular is an active private limited company based in Mumbai, Maharashtra, India. The company works in medical and laboratory equipment, within the healthcare industry. It was incorporated on 27 August 2007 (19+ years old) and is registered under CIN U85100MH2007PTC173490.
Purple Microport Cardiovascular has 3 current directors:
- Brian Savio Lancelot - Director
- Rajesh Hiralal Shrivas - Director
- Jonathan W Chen - Director
The latest financial statements of Purple Microport Cardiovascular on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 19 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Purple Microport Cardiovascular is 27AAECP3664L1Z0, registered in Maharashtra. The company has 6 GST registrations in all, of which 4 are active and 2 are cancelled or inactive. Other active GSTINs include 32AAECP3664L1Z9 (Kerala), 07AAECP3664L2Z1 (Delhi), 24AAECP3664L2Z5 (Gujarat).
The CIN (Corporate Identification Number) of Purple Microport Cardiovascular is U85100MH2007PTC173490. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Purple Microport Cardiovascular has 2 court cases on record: 2 filed by the company.
Purple Microport Cardiovascular was incorporated on 27 August 2007, making it 19+ years old. It is registered with the Registrar of Companies, Mumbai.
Purple Microport Cardiovascular has 9 deals on record (6 secondary share transfers, 3 funding rounds), with disclosed funding of ₹55.08 Cr; the latest was in December 2021.
Jonathan W Chen was appointed as Director on 11 Nov 2021. Mathew Thundiyl Thomas ceased to be Director on 24 Mar 2020. Murlidhar Baliram Bendale ceased to be Director on 24 Mar 2020. Purple Microport Cardiovascular has 9 board changes on record in total.
Yes, Purple Microport Cardiovascular is registered as a medium enterprise under Udyam registration (number: UDYAM-MH-19-0004490).

